# Aura Biosciences, Inc.: Form 8-K, filed Jun 18, 2025

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: 8-K
- Filed: 2025-06-18
- Accepted by EDGAR: Jun 18, 2025, 16:06 ET
- Period: 2025-06-17
- Accession: 0000950170-25-087885
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000095017025087885/aura-20250617.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000095017025087885/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000095017025087885/aura-20250617.htm

Filed Jun 18, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-087885. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.